← Back
$BLFS All transactions

BIOLIFE SOLUTIONS INC

▼ SELL 10b5-1 Plan

$ Value

$11K

Shares

529

Price

$21

Filed

Mar 5

Insider

Name

Mathew Aby J.

Title

EVP & Chief Scientific Officer

CIK

0001556355

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

392,937

Footnotes

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Filing Info

Accession No.

0001628280-26-015340

Form Type

4

Issuer CIK

0000834365

Mathew Aby J.'s History

Date Ticker Type Value
2026-04-08 BLFS F $10K
2026-03-19 BLFS F $43K
2026-03-03 BLFS $11K
2026-02-24 BLFS A
2026-02-24 BLFS A
2026-02-24 BLFS F $353K
2026-01-06 BLFS $10K
2025-12-09 BLFS $16K
2025-11-25 BLFS $14K
2025-10-09 BLFS $14K

Other Insiders at BLFS (90d)

Insider Bought Sold Last
DE GREEF RODERICK
President and CEO
2026-03-19
GOSWAMI JOYDEEP 2026-02-24
Mathew Aby J.
EVP & Chief Scientific Officer
2026-04-08
Ellingson Rachel 2026-02-24
Hunt Anthony 2026-02-24
Berard Todd
Chief Marketing Officer
$7K 2026-04-08
MOORE TIMOTHY L. 2026-02-24
Foster Karen A.
Chief Quality and Operations
$2.0M 2026-03-23
Coste Catherine 2026-02-24
Aebersold Sarah
Chief Human Resources Officer
$5K 2026-03-19
DuRoss Amy 2026-02-24
Wichterman Troy
Chief Financial Officer
$12K 2026-04-08
Werner Sean
Chief Technology Officer
$2K 2026-03-19